Northern Trust Corp Adaptive Biotechnologies Corp Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,053,590 shares of ADPT stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,053,590

Previous 1,093,981 3.69%

Holding current value

$11.2 Million

Previous $6.56 Million 19.27%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$6.07 - $8.66 $245,173 - $349,786	-40,391 Reduced 3.69%	1,053,590 $7.83 Million
Q4 2024 Feb 14, 2025	BUY	$4.37 - $6.78 $570,062 - $884,444	130,449 Added 13.54%	1,093,981 $6.56 Million
Q3 2024 Nov 13, 2024	BUY	$3.37 - $5.12 $120,143 - $182,533	35,651 Added 3.84%	963,532 $4.93 Million
Q2 2024 Aug 14, 2024	SELL	$2.34 - $3.96 $225,225 - $381,150	-96,250 Reduced 9.4%	927,881 $3.36 Million
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $54,299 - $90,499	-18,854 Reduced 1.81%	1,024,131 $3.29 Million
Q4 2023 Feb 13, 2024	BUY	$3.46 - $5.33 $28,243 - $43,508	8,163 Added 0.79%	1,042,985 $5.11 Million
Q3 2023 Nov 13, 2023	SELL	$5.07 - $8.44 $72,171 - $120,143	-14,235 Reduced 1.36%	1,034,822 $5.64 Million
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $101,212 - $143,561	16,351 Added 1.58%	1,049,057 $7.04 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $290,916 - $377,072	37,297 Added 3.75%	1,032,706 $9.12 Million
Q4 2022 Feb 13, 2023	SELL	$6.26 - $9.34 $1.07 Million - $1.59 Million	-170,425 Reduced 14.62%	995,409 $7.6 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $1 Million - $1.95 Million	154,272 Added 15.25%	1,165,834 $8.3 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $3.5 Million - $8.06 Million	547,304 Added 117.89%	1,011,562 $8.18 Million
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $21,747 - $62,106	-2,149 Reduced 0.46%	464,258 $6.44 Million
Q4 2021 Feb 08, 2022	SELL	$25.17 - $36.85 $297,333 - $435,309	-11,813 Reduced 2.47%	466,407 $13.1 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $454,923 - $604,189	15,154 Added 3.27%	478,220 $16.3 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $1.4 Million - $1.94 Million	43,596 Added 10.39%	463,066 $18.9 Million
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $355,236 - $645,833	9,534 Added 2.33%	419,470 $16.9 Million
Q4 2020 Feb 11, 2021	BUY	$45.01 - $65.47 $31,822 - $46,287	707 Added 0.17%	409,936 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $1.77 Million - $2.41 Million	49,463 Added 13.75%	409,229 $19.9 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $368,885 - $715,298	-14,785 Reduced 3.95%	359,766 $17.4 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $4.44 Million - $8.93 Million	261,558 Added 231.48%	374,551 $10.4 Million
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $17,216 - $22,992	-701 Reduced 0.62%	112,993 $3.38 Million
Q3 2019 Nov 13, 2019	BUY	$30.31 - $53.51 $3.45 Million - $6.08 Million	113,694 New	113,694 $3.51 Million
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $0 - $0	0 New	0 $0

Others Institutions Holding ADPT

# of Institutions

246

Shares Held

156M

Call Options Held

44.3K

Put Options Held

47.8K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.52B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Adaptive Biotechnologies Corp Transaction History